LIT scientists Dr. Astrid Holzinger, Dr. Markus Barden and Prof. Hinrich Abken give an overview on CARs, TRUCKS and the next generation of T cell therapy in the journal JATROS Hämatologie & Onkologie.
The Leibniz Institute for Immunotherapy (LIT) is pleased to announce the successful completion of Dr. Roland C. Schelker’s second doctoral degree.
Prof. Philipp Beckhove, Scientific Director of the LIT, was guest in the podcast “ImmunVERMITTELT” by Janssen-Cilag GmbH.
Recent work by LIT scientists Prof. Luca Gattinoni and Dr. Jeremy Baldwin published in Cell has generated significant interest both inside and outside the cancer immunology field.
Dr. Caio Silveira, postdoctoral scientist in the Research Division ‘Functional Immune Cell Modulation’, participated in a new campaign by the Federal Ministry of Education and Research (BMBF).
LIT scientists Prof. Hinrich Abken, Prof. Markus Feuerer, Prof. Luca Gattinoni and Prof. Michael Rehli are featured in the prestigious Stanford ranking of the world’s top 2% of scientists.
The LIT Retreat took place on September 16 and 17, 2024 at Schloss Hirschberg.
Gabriele Inchingolo was honored as one of the Best Abstract Awardees at the 3rd Translational Research Conference “IMMUNE & CELLULAR THERAPIES: Focus on Advanced Gene-Engineered Immune Cells” September 13-15, 2024 in Malahide (Dublin), Ireland.
An international team of researchers, led by Professor Luca Gattinoni at the Leibniz Institute for Immunotherapy (LIT), has developed an innovative mitochondrial transfer platform to supercharge CD8+ T cells, enabling them to overcome exhaustion and more effectively fight tumor cells.
Prof. Philipp Beckhove, Scientific Director of the LIT, was guest in the podcast “Tonspur Wissen” by Leibniz Association and Rheinische Post. He talked with journalist Ursula Weidenfeld about new developments in fighting cancer with immunotherapy (in German).
